1 Du Plessis M, Cloete M, Aitchison H, et al. Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines.Onderstepoort J Vet Res,1998,65(4):321~329 2 Coetzer J A, Erasmus B J. African horsesickness. In: Coetzer J A, Thomson G R, Tustin R C. Infectious diseases of livestock with special reference to southern Africa. Vol, 1. Cape Town: Oxford University Press, 1994.460~475 3 Roy P, Mertens P P, Casal I. African horse sickness virus structure. Comp Immunol Microbiol Infect Dis,1994,17(3~4): 243~273 4 Howell P G. The isolation and identification of further antigenic types of African horse sickness virus. Onderstepoort J Vet Res, 1962,(29): 139~149 5 Iwata H, Yamagawa M, Roy P. Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences. Virology, 1992,191(1): 251~261 6 Bremer C W, Huismans H, Van Dijk A A. Characterization and cloning of the African horsesickness virus genome.J Gen Virol,1990,(71): 793~799 7 Vreede F T, Huismans H. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3.J Gen Virol, 1994,(75): 3629~3633 8 Martinez-Torrecuadrada J L, Langeveld J P, Venteo A, et al. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus. Virology, 1999,257(2):449~459 9 Oellermann R A, Els H J, Erasmus B J. Characterization of African horsesickness virus.Arch Gesamte Virusforsch, 1970,29(2):163~174 10 Maree S, Paweska J T. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.J Virol Methods, 2005,125(1): 55~65 11 Chuma T, Le Blois H, Sanchez-Vizcaino J M, et al. Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.J Gen Virol,1992,(73): 925~931 12 Basak A K, Gouet P, Grimes J, et al. Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.J Virol, 1996,70(6): 3797~3806 13 Maree S, Durbach S, Huismans H. Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.J Gen Virol,1998,(79):333~337 14 Wade-Evans A M, Pullen L, Hamblin C, et al. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.J Gen Virol,1997,(78):1611~1616
|